Imagine watching your dog waddle into the room and noticing that he is walking on the top of his back paw. While you may classify it as a harmless quirk, ...
Opthea’s lead product candidate, sozinibercept, is being evaluated in two fully enrolled pivotal Phase 3 clinical trials (COAST, NCT04757636, and ShORe, NCT04757610) for use in combination with ...
New System Enhances Surgical Efficiency and Provides Versatile Solutions for Complex Spine ProceduresBELGRADE, MT / ACCESSWIRE / September 23, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), ...
(NYSE American:XTNT), a leading global medical technology company focused on the treatment of spinal disorders ... portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in ...